Endothelin (ET-1), an endogenous peptide with a prominent role in cutaneous pain, causes mechanical hypersensitivity in the rat hind paw, partly through mechanisms involving local release of algogenic molecules in the skin. The present study investigated involvement of cutaneous ATP, which contributes to pain in numerous animal models. Pre-exposure of ND7/104 immortalized sensory neurons to ET-1 (30 nM) for 10 min increased the proportion of cells responding to ATP (2 lM) with an increase in intracellular calcium, an effect prevented by the ET A receptor-selective antagonist BQ-123. ET-1 (3 nM) pre-exposure also increased the proportion of isolated mouse dorsal root ganglion neurons responding to ATP (0.2-0.4 lM). Blocking ET-1-evoked increases in intracellular calcium with the IP 3 receptor antagonist 2-APB did not inhibit sensitization to ATP, indicating a mechanism independent of ET-1-mediated intracellular calcium increases. ET-1-sensitized ATP calcium responses were largely abolished in the absence of extracellular calcium, implicating ionotropic P2X receptors. Experiments using quantitative polymerase chain reaction and receptor-selective ligands in ND7/104 showed that ET-1-induced sensitization most likely involves the P2X4 receptor subtype. ET-1-sensitized calcium responses to ATP were strongly inhibited by broad-spectrum (TNP-ATP) and P2X4-selective (5-BDBD) antagonists, but not antagonists for other P2X subtypes. TNP-ATP and 5-BDBD also significantly inhibited ET-1-induced mechanical sensitization in the rat hind paw, supporting a role for purinergic receptor sensitization in vivo. These data provide evidence that mechanical hypersensitivity caused by cutaneous ET-1 involves an increase in the neuronal sensitivity to ATP in the skin, possibly due to sensitization of P2X4 receptors. Ó
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Introduction
Endothelin-1 (ET-1) is a potent vasoactive peptide that also plays a prominent role in peripheral pain, but its mechanisms are complex and incompletely understood. ET-1 acts through two G-protein-coupled receptors (ET A and ET B ) on neuronal and nonneuronal cells in the skin to mediate both pro-and antinociceptive effects [3, 17] . When injected into the rat plantar hind paw, ET-1 at high doses causes overt pain (as indicated by robust hind paw flinching) and sensitization to thermal and mechanical stimulation.
Lower doses of ET-1 are also capable of producing tactile sensitization but do not cause overt pain [12] . The overt pain elicited by subcutaneous ET-1 injection into the paw has been almost exclusively attributed to the direct activation of ET A receptors on nociceptive sensory neurons that innervate the skin because these nerves express ET A receptors and increase their firing in vivo in response to ET-1 administration [12, 28] . ET A receptor activation also results in enhanced excitability in the soma of isolated nociceptive primary sensory neurons, through alterations in ionic currents and sensitization of excitatory receptors. Activation of ET A receptors promotes TTX-sensitive sodium currents, reduces delayed rectifier potassium currents and sensitizes TRPV1 receptors, all processes that likely contribute to tactile sensitization after ET-1 administration [10, 24, 32, 35] . 
